These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17510028)

  • 21. Integrating pharmacogenomics into pharmacy practice via medication therapy management.
    Reiss SM;
    J Am Pharm Assoc (2003); 2011; 51(6):e64-74. PubMed ID: 22001957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacists' experiences and attitudes regarding generic drugs and generic substitution: two sides of the coin.
    Olsson E; Kälvemark Sporrong S
    Int J Pharm Pract; 2012 Dec; 20(6):377-83. PubMed ID: 23134096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacists' awareness of clinical decision support in pharmacy information systems: an exploratory evaluation.
    Hines LE; Saverno KR; Warholak TL; Taylor A; Grizzle AJ; Murphy JE; Malone DC
    Res Social Adm Pharm; 2011 Dec; 7(4):359-68. PubMed ID: 21530417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solution-driven approaches to generic substitution challenges - a survey among international experts.
    Drozdowska A; Hermanowski T
    Fundam Clin Pharmacol; 2015 Dec; 29(6):592-603. PubMed ID: 26214281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical therapeutic categories: a contraindication to generic substitution?
    Colaizzi JL; Lowenthal DT
    Clin Ther; 1986; 8(4):370-9. PubMed ID: 3731208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of Variation in State Regulation of Generic Drug and Interchangeable Biologic Substitutions.
    Sacks CA; Van de Wiele VL; Fulchino LA; Patel L; Kesselheim AS; Sarpatwari A
    JAMA Intern Med; 2021 Jan; 181(1):16-22. PubMed ID: 32865564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The US Food and drug administration: drug information resource for formulary recommendations.
    Marchand HC; Ros BJ; Fine AM; Kremzner ME
    J Manag Care Pharm; 2012; 18(9):713-8. PubMed ID: 23206214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APhA 2011 REMS white paper: Summary of the REMS stakeholder meeting on improving program design and implementation.
    American Pharmacists Association ; Bough M
    J Am Pharm Assoc (2003); 2011; 51(3):340-58. PubMed ID: 21555285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the pharmacist in preventing distribution of counterfeit medications.
    Chambliss WG; Carroll WA; Kennedy D; Levine D; Moné MA; Ried LD; Shepherd M; Yelvigi M
    J Am Pharm Assoc (2003); 2012; 52(2):195-9. PubMed ID: 22370383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medication therapy management: 10 years of experience in a large integrated health care system.
    Ramalho de Oliveira D; Brummel AR; Miller DB
    J Manag Care Pharm; 2010 Apr; 16(3):185-95. PubMed ID: 20331323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transplant pharmacists' opinions on generic product selection of critical-dose drugs.
    Vasquez EM; Min DI
    Am J Health Syst Pharm; 1999 Apr; 56(7):615-21. PubMed ID: 10423207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integration of temperature-controlled requirements into pharmacy practice.
    Ziance R; Chandler C; Bishara RH
    J Am Pharm Assoc (2003); 2009; 49(3):e61-7; quiz e68-9. PubMed ID: 19443313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experience with a clinical decision support system in community pharmacies to recommend narrow-spectrum antimicrobials, nonantimicrobial prescriptions, and OTC products to decrease broad-spectrum antimicrobial use.
    Madaras-Kelly KJ; Hannah EL; Bateman K; Samore MH
    J Manag Care Pharm; 2006 Jun; 12(5):390-7. PubMed ID: 16792446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evidence-based pharmacology in community and hospital pharmacies--a vision of the future?].
    Eisert A; Günther J
    Z Arztl Fortbild Qualitatssich; 2003 Jul; 97(4-5):263-70. PubMed ID: 12891967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perceptions of pharmacists and physicians on generic substitution in a financial crisis context in Northwestern Spain: A qualitative study.
    Mondelo-García C; Mendoza E; Movilla-Fernández MJ; Coronado C
    Health Policy; 2018 Dec; 122(12):1316-1325. PubMed ID: 30201184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Opinions and attitudes of Flemish pharmacists and general practitioners towards INN prescribing. A survery in Antwerp and East Flanders].
    Fraeyman J; De Winter J; De Loof H; Van Hal G; Beutels P; Remmen R; De Meyer GR
    J Pharm Belg; 2013 Jun; (2):18-31. PubMed ID: 23798183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmaco-legal considerations in the clinical use of decongestants.
    Brushwood DB
    Pharmacotherapy; 1993; 13(6 Pt 2):135S-142S; discussion 143S-146S. PubMed ID: 7507591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.